Internal Medicine, Pulmonary Disease · Bronx, NY
NPI
1407913528
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3322 Bainbridge Ave
Bronx, NY, 10467
Phone (718) 882-0090
Groups this clinician bills Medicare through
Medicare paid, 2024
$163K
6,427 services
Medicare patients, 2024
291
Average age 76
Drug cost, 2024
$2.5M
6,937 prescriptions
Company payments, 2025
$2,337
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard V Deluca was code 95004 (test - miscellaneous), 3,070 times for 51 patients. In total Richard V Deluca billed 6,427 services in 20 codes, and Medicare paid $163K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-01-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 3,070 | 51 | $3.35 | $10K |
| 94375 Pulmonary Function Testing | Office | 728 | 283 | $33.20 | $24K |
| 99214 Office E&M - Established | Office | 587 | 245 | $105.83 | $62K |
| 94729 Pulmonary Function Testing | Office | 323 | 260 | $48.85 | $16K |
| 94726 Pulmonary Function Testing | Office | 245 | 202 | $48.44 | $12K |
| 99213 Office E&M - Established | Office | 89 | 39 | $76.31 | $6,792 |
| 94727 Pulmonary Function Testing | Office | 79 | 72 | $38.51 | $3,042 |
| 94664 E&M - Miscellaneous | Office | 75 | 74 | $16.08 | $1,206 |
| 99204 Office E&M - New | Office | 62 | 62 | $132.28 | $8,201 |
| 99406 Behavioral Health Services | Office | 41 | 25 | $15.48 | $634 |
| 99215 Office E&M - Established | Office | 33 | 32 | $143.46 | $4,734 |
By year: 2022 $148K for 4,326 services; 2023 $174K for 6,474 services; 2024 $163K for 6,427 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard V Deluca prescribed most often to Medicare patients was Fluticasone Propionate, with 1,292 prescriptions and refills. In total Richard V Deluca wrote 6,937 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 1,292 | 2,613 | 460 | $17K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,165 | 1,761 | 337 | $52K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 899 | 1,309 | 233 | $807K |
| Prednisone Generic | 599 | 865 | 266 | $2,259 |
| Azelastine Hcl Generic | 430 | 903 | 163 | $11K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 426 | 774 | 131 | $471K |
| Montelukast Sodium Generic | 343 | 807 | 110 | $4,184 |
| Azithromycin Generic | 322 | 336 | 191 | $1,513 |
| Breo Ellipta Fluticasone/Vilanterol | 174 | 302 | 44 | $114K |
| Incruse Ellipta Umeclidinium Bromide | 166 | 254 | 29 | $85K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 135 | 291 | 55 | $33K |
| Symbicort Budesonide/Formoterol Fumarate | 109 | 183 | 53 | $39K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 102 | 240 | 48 | $40K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 88 | 175 | 31 | $17K |
| Ventolin Hfa Albuterol Sulfate | 68 | 98 | 19 | $5,546 |
Brand drugs: - claims; generic drugs: 3,968 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard V Deluca $2,337 ($2,337 in general payments such as food, travel and fees) from 10 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $768.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 29 | $768 |
| GlaxoSmithKline, LLC. GSK | 21 | $479 |
| Genzyme Corporation SNY | 13 | $288 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $229 |
| Insmed, Inc. INSM | 15 | $181 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $144 |
| Viatris Specialty LLC | 4 | $101 |
| Baxter Healthcare BAX | 5 | $92.66 |
| Amgen Inc. AMGN | 1 | $28.17 |
| Philips North America LLC PHG | 1 | $26.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.